Immuneering Corp (IMRX) Financials

$4.91

$-0.14 (-2.68%)

As on 04-Sep-2026 13:36EDT

Market cap

$323 Mln

Revenue (TTM)

$0 Mln

P/E Ratio

--

P/B Ratio

1.8

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Operating Revenue	0.36	--	--	0.00	0.32	2.08
Cost of Revenue	1.06	0.70	0.71	0.76	0.16	1.15
Gross Profit	-0.70	-0.70	-0.71	-0.76	0.16	0.93
Operating Expenses	62.68	58.68	64.07	58.41	51.90	34.81
Operating Profit (EBIT)	-63.47	-59.38	-64.07	-58.41	-51.74	-33.89
Other Income	--	--	--	--	1.25	-0.01
Profit before Tax	-57.28	-56.02	-61.04	-53.47	-50.51	-33.84
Provision for Tax	--	--	--	0.00	-1.23	-0.31
Profit after Tax (Net Income)	-57.28	-56.02	-61.04	-53.47	-50.51	-33.54
Minority Interest	--	--	--	--	--	--
Consolidated Profit	--	--	--	--	-50.51	-33.54

Liabilities ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Shareholder's Funds	190.74	218.48	41.39	90.58	109.85	155.98
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	3.20	3.43	3.82	4.16	4.46	5.09
Current Liabilities	8.12	10.07	7.50	7.85	8.05	5.63
Total Liabilities	210.17	231.99	52.71	102.58	122.37	166.70

Assets ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Non-Current Assets	44.06	55.74	13.13	13.50	13.62	14.37
Current Assets	157.99	176.25	39.59	89.08	108.75	152.33
Total Assets	210.17	231.99	52.71	102.58	122.37	166.70
Total Debt*	3.63	3.82	4.16	4.46	4.84	5.36
Net Current Assets	149.87	166.17	32.08	81.24	100.69	146.70

Cashflow ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Cash From Operating Activities	--	-45.34	-55.00	-48.97	-44.10	-30.85
Cash Flow from Investing Activities	--	-88.74	26.43	7.30	41.83	-75.62
Cash from Financing Activities	--	226.58	5.30	28.44	0.02	144.26
Net Cash Inflow / Outflow	--	--	--	--	-2.25	37.80

Financials Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Adjusted EPS ($)	-1.03	-0.87	-1.97	-1.83	-1.91	-1.29
Cash EPS ($)	--	-0.86	-1.95	-1.80	-1.88	-1.28
Adjusted Book Value ($)	--	3.38	1.33	3.09	4.16	6.00
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	-0.70	-1.77	-1.67	-1.67	-1.19
Free Cash Flow per Share ($)	--	-0.70	-1.77	-1.68	-1.70	-1.19

Profitability Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
ROCE (%)	--	-41.83	-86.83	-50.99	-36.60	-48.09
ROE (%)	-27.99	-43.12	-92.51	-53.36	-38.00	-50.24
ROA (%)	-44.45	-39.36	-78.61	-47.54	-34.95	-32.70
EBIT Margin (%)	-17,219.28	--	--	-12,838,084.62	-16,325.92	-1,629.17
Net Margin (%)	-15,867.83	--	--	-11,752,004.84	-3,223.29	-1,617.13
Cash Profit Margin (%)	-0.05	--	--	--	--	--

Growth Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Revenue Growth (%)	-50.30	--	-1.00	-1.00	-0.85	-0.10
EBIT Growth (%)	2.22	12.56	-9.69	-12.89	-52.70	-98.37
Net Profit Growth (%)	7.81	8.21	-14.15	-5.86	-50.63	-96.81
EPS Growth (%)	45.56	0.56	-0.08	0.04	-0.48	-0.02
Book Value Growth (%)	266.64	--	--	--	--	--

Valuation Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Price / Earnings	--	-7.59	-1.12	-4.02	-2.54	-12.53
Price / Book Value	1.77	1.95	1.65	2.38	1.17	2.69
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	-1.53	-4.63	-567.54	-2.31	-0.53	-8.19
Close Price ($)	4.99	6.58	2.20	7.35	4.85	16.17
High Price ($)	10.08	10.08	7.68	14.29	17.36	33.99
Low Price ($)	2.90	1.10	1.00	3.70	3.74	15.00
Market Cap ($ Cr)	322.84	--	--	--	--	--

Solvency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debt to Equity	--	0.02	0.10	0.05	0.04	0.03
Short term debt to equity ratio	0.00	0.00	0.01	0.00	0.00	0.00
Current Ratio	19.47	17.50	5.28	11.35	13.50	27.04
Quick Ratio	19.47	--	--	--	13.50	40.23
Interest Coverage	--	--	--	--	-51.01	-167.83

Operating Efficiency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debtors to sales (%)	935.67	--	--	--	3.92	11.83
Asset Turnover	0.00	--	--	0.00	0.00	0.02
Receivable days	--	--	--	4,983.86	148.92	65.51
Inventory Days	--	--	--	0.00	-85,826.66	-23,538.98
Payable days	--	914.91	1,041.87	1,258.60	5,253.81	455.33
Cash Conversion Cycle	--	--	--	3,725.26	-90,931.55	-23,928.80

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.